US Patent 7638554 Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
Patent 7638554 was granted and assigned to SRI International on December, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Nahid Waleh0
Nurulain T. Zaveri0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+235 characters)
Article
Patent abstract
Compounds useful as chemotherapeutic, chemopreventive, and antiangiogenic agents are provided. The compounds are flavanoids, including flavanones, flavanols, and chalcones. The compounds have the structure of formula (I)
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07638554 Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents US Patent 7638554 Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
Infobox
Patent Number
076385540
Patent Number
76385540
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076385540
Date of Patent
December 29, 2009
0Patent Application Number
114042300
Date Filed
April 14, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07638554 Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07638554
Date of patent
December 29, 2009
Patent application number
11404230
Date Filed
April 14, 2006
Patent primary examiner
Find more entities like US Patent 7638554 Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.